Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients

Insulin Resistance Clinical Trial

Official title:

Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients by the Homeostasis Model Assessment Index (HOMA2-IR)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06163768
• Other study ID #: Nguyen Ngoc Minh Thu
• Status: Recruiting
• Phase: N/A
• Start date: December 31, 2023
• Est. completion date: December 30, 2026

Study information

• Verified date: December 2023
• Source: University of Medicine and Pharmacy at Ho Chi Minh City
• Contact: Nguyen Ngoc Minh Thu
• Phone: +84907484296
• Email: nnmthu.ncs.khys.hoasinh23[@]ump.edu.vn
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Effects of insulin resistance in non-diabetic acute coronary syndrome patients by the homeostasis model assessment index (HOMA2-IR)

Description:

Help patients know about insulin resistance. If this condition persists for a long time, it will reduce the ability to produce insulin, thereby leading to increased blood sugar levels, causing type 2 diabetes. Helping doctors have a more general view, in order to come up with a strategy more effective monitoring and treatment, preventing diabetes and cardiovascular events.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1
• Est. completion date: December 30, 2026
• Est. primary completion date: October 31, 2026
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Control group The researcher collected samples from healthy people over 18 years old who came for a health check and were concluded to have good health at the Health Examination Department of University of Medicine and Pharmacy Hospital, Ho Chi Minh City. Not falling within the exclusion criteria and agreeing to participate in the study were included in the study.

• Researchers -All patients diagnosed with Acute coronary syndrome who were over 18 years old, met the inclusion criteria and did not have exclusion criteria, and agreed to participate in the study were included in the study.

Exclusion Criteria:

• Control group

• Patients < 18 years old.

• History of heart disease or stroke

• Exclude diabetic subjects

• Exclude subjects at high risk of insulin resistance

• Researchers

• Have diabetes or have previously been diagnosed with diabetes.

• Patients < 18 years old.

• The patient does not participate in follow-up examinations and does not follow up treatment at the medical facility.

• The patient died before reaching the hospital.

• Patients with severe medical diseases: cirrhosis, cancer, obstructive pulmonary disease chronic obstructive pulmonary disease, chronic heart failure, severe kidney failure.

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Insulin Resistance

Intervention

Procedure:
• Insulin resistance
Steps to conduct testing and treatment according to the approved regimen at Ho Chi Minh City University of Medicine and Pharmacy Hospital. The researcher did not intervene in the treatment process.

Locations

Country	Name	City	State
Vietnam	Medical and Pharmaceutical University Hospital	Ho Chi Minh City	Five

Sponsors (1)

Lead Sponsor	Collaborator
University of Medicine and Pharmacy at Ho Chi Minh City

Country where clinical trial is conducted

Vietnam, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Model HOMA-IR	Use SPSS software to analyze data	January 2026